RybelsusPalo Alto, CA

Rybelsus in Palo Alto, CA

Accessing GLP-1 treatment in Palo Alto, California has traditionally meant longer waits than mainland patients face. Rybelsus® is the FDA-approved Oral tablet Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Palo Alto address at $199/month. Compounded Semaglutide is not FDA-approved.

FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Palo Alto is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Rybelsus in Palo Alto, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Palo Alto from $199/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Rybelsus® by Novo Nordisk is the FDA-approved Oral tablet Semaglutide product, taken Once daily and approved in 2019 for Type 2 diabetes. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Palo Alto residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.

What treatment options are available locally?

Research suggests Semaglutide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In Palo Alto, Weight Method pairs compounded Semaglutide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $199/month.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Rybelsus® is a Oral tablet manufactured by Novo Nordisk, FDA-approved since 2019 for Type 2 diabetes. It contains Semaglutide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Rybelsus® is taken Once daily. Weight Method does not sell Rybelsus®; we are a separate program that prescribes compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $199/month.

Yes. Weight Method's licensed providers in California can prescribe compounded Semaglutide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Semaglutide is shipped directly to your Palo Alto address. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $199/month.

Rybelsus® is the FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk. Weight Method prescribes compounded Semaglutide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Semaglutide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Semaglutide is an appropriate option based on your medical history.

Weight Method's compounded Semaglutide program starts at $199/month in Palo Alto. That price includes the medication, licensed provider consultations, and free home delivery. We don't bill insurance — there are no copays, no prior authorizations, and no surprise charges. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. Rybelsus® is a separate FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk; its retail price varies by pharmacy.

Weight Method is a telehealth program. You take an online health assessment, a licensed California provider reviews your history and meets with you virtually, and — if appropriate — they prescribe compounded Semaglutide, which is dispensed by a U.S.-licensed 503A compounding pharmacy and shipped to your Palo Alto address. The $199/month price covers the medication, the virtual provider consultations, dosing management, and free delivery — there are no hidden fees. Compounded Semaglutide is not FDA-approved.

Start Your Treatment

Consult with a licensed provider in California and start Rybelsus from $199/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Palo Alto

Ozempic in Palo AltoWegovy in Palo AltoMounjaro in Palo AltoZepbound in Palo AltoSemaglutide in Palo Alto

Nearby Cities

Rybelsus in Menlo Park, CARybelsus in Los Altos, CARybelsus in Redwood City, CARybelsus in Mountain View, CA

See More

All About RybelsusSemaglutide in Palo AltoClinics in Palo Alto